Found 19 matching trials
Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients PHASE2 The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Show More Learn More & Join Trial
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer PHASE1 The intention of this trial is to determine the maximum tolerated of the tr...
Show More Location
Bellevue Hospital
Learn More & Join Trial
Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer PHASE2 This study will compare the safety and efficacy of sunitinib in combination...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy PHASE2 The purpose of this study is to estimate the usefulness and safety of HD661...
Show More Location
Jiangsu Province Hospital of Integrated Chinese and Western Medicine
Learn More & Join Trial
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer PHASE2 The purpose of this study is to test how long participants with colorectal ...
Show More Location
ImClone Investigational Site
Learn More & Join Trial
Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer NA This study investigates the possible protective role of N-Acetylcysteine ag...
Show More Location
Tanta University - Faculty of Medicine ,oncology department, Tanta university hospital.
Learn More & Join Trial
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors PHASE2 The primary objective of this study is to estimate the treatment effect on ...
Show More Learn More & Join Trial
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) PHASE2 The purpose of this protocol is to allow continued treatment with conatumum...
Show More Learn More & Join Trial
A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy PHASE2 The objective of this study is to compare the progression free survival (PF...
Show More Location
Banner MD Anderson Cancer Research Center
Learn More & Join Trial
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer PHASE2 Brief Summary:
This study is for patients with advanced biliary tract canc...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial